Xi'an, China

Bin Tian

This inventor holds 29 USPTO granted patents and 1 published patent application, primarily in Pharmaceutical Chemistry. Top assignees: Shaanxi University of Science and Technology, Xi'an Taikomed Pharmaceutical Technology Co., Ltd., Xi'an Kangyuansheng Biomedical Technology Co., Ltd.. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin Tian. Retrieved from https://idiyas.com/inventor/bin-tian-r8zlgsbh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29 

% Patents Active = 44.8

Average Co-Inventor Count = 11.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Xi+3 an, CN (2022)
  • Xi'an, CN (2019 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Areas of Expertise:
Dihydromyricetin
Hydroxytyrosol
Pleuromutilin
Antibacterial Activity
Antioxidant Activity
Silibinin
Hepatoprotective
Cinnamyl Alcohol
Cardiovascular Diseases
Herbal Medicine
Preparation Method
Drug Resistance
29 patents (USPTO):Explore Patents

Title: **Bin Tian: Innovator in Nanotechnology and Biopolymers**

Introduction

Bin Tian is a prolific inventor based in Xi'an, China, known for his innovative work in nanotechnology and biopolymers. With a remarkable portfolio of 29 patents, he has made substantial contributions to the fields of materials science and biomedical applications. His latest patents reflect his commitment to creating environmentally friendly and efficient methods for producing valuable materials.

Latest Patents

One of Bin Tian's latest inventions is the patent for "Dihydromyricetin nanocrystals and preparation method and application thereof." This invention details a straightforward method for preparing dihydromyricetin nanocrystals, which includes dispersing dihydromyricetin in a solvent to obtain a solution, followed by mixing it with a stabilizer in water to form a nanocrystal solution. This process is characterized by low costs, high stability, reduced organic solvent consumption, and a safety-focused preparation method that is environmentally friendly.

Another notable patent is for a "Hydroxytyrosol sturgeon skin gelatin film with antioxidant activity and detection ability and a method of preparing the same." This method involves creating a gelatin film from sturgeon skin that combines hydroxytyrosol and exhibits significant antioxidant properties. The preparation process includes mixing solutions, heating, and ultrasonicating the ingredients to produce a functional gelatin film, showcasing Tian's innovative approach to material science.

Career Highlights

Bin Tian has had a distinguished career, collaborating with reputable institutions like Shaanxi University of Science and Technology and Xi'an Taikomed Pharmaceutical Technology Co., Ltd. His roles in these organizations have allowed him to push the boundaries of research and innovation, contributing significantly to advancements in his fields of expertise.

Collaborations

Throughout his career, Bin Tian has worked with talented individuals such as Han Li and Chengyuan Liang. These collaborations have fostered a dynamic exchange of ideas and have likely contributed to the development of his innovative patents and research initiatives.

Conclusion

Bin Tian's contributions to nanotechnology and biopolymers through his extensive patent portfolio underscore his role as a leading innovator. His focus on creating sustainable and efficient materials not only advances scientific inquiry but also holds the promise of practical applications in various industries. As he continues to progress in his career, the impact of his inventions on technology and society will undoubtedly be profound.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…